PMS2 and nasopharyngeal carcinoma: Of 69 patients with stage II-IVa NPC, 35 (50.7%) patients showed preserved PMS2 expression, 53 (76.8%) patients showed preserved MLH1 expression, and 68 (98.6%) patients showed preserved MSH2 or MSH6 expression.